Actuate Therapeutics (ACTU) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is Actuate Therapeutics (NASDAQ:ACTU) In A Good Position To Deliver On Growth Plans?
Yahoo FinanceFeb 12 05:55 ET
Actuate Therapeutics to Participate in Upcoming Investor Conferences in February
GlobeNewswireFeb 6 08:00 ET
Top Premarket Gainers
MT NewswiresJan 27 07:42 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaJan 24 16:05 ET
NASDAQ New 52-Week Highs And Lows
Dow JonesJan 23 12:21 ET
Actuate Therapeutics Gets Orphan Medicinal Product Label for Elraglusib in EU
MT NewswiresJan 7 10:34 ET

Comments

Jaguar8

Jan 7 07:13

NEWS

$Actuate Therapeutics (ACTU.US)$
Actuate Therapeutics Receives EMA Orphan Medicinal Product Designation for Elraglusib for the Treatment of Pancreatic Cancer
Tuesday, 7th January at 8:00 am
CHICAGO and FORT WORTH, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) ("Actuate" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen...

Jaguar8

Dec 17, 2024 16:55

🟡Watchlist WEDNESDAY December 18,2024

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months✅
$Wearable Devices (WLDS.US)$ PR 12/17:...

Trump announces $500 billion "Stargate" project! Powerful catalyst for AI?

58

18

3

Jaguar8

Dec 17, 2024 07:06

NEWS

$Actuate Therapeutics (ACTU.US)$
Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer
Tuesday, 17th December at 8:00 am
• Statistical Significance Met on Primary Endpoints of 1 Year Survival Rate and Median Overall Survival
• Doubling of 1 Year Survival Rate and 37% Reduction in Risk of Death
• Two Month (29%) Increase in Median Overall Survival
• Multiple Patients with Complete Responses (CRs) and/or Partial Re...

1

2

BomBstar

Dec 16, 2024 03:57

$Actuate Therapeutics (ACTU.US)$ buy the dip?

Teddy123

Oct 29, 2024 22:55

Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development

$Actuate Therapeutics (ACTU.US)$
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...

ACTU Actuate Therapeutics

Trade Overview

Capital Trend

News

Comments